EDAP TMS S.A. FOCL

Company Overview

EDAP TMS S.A. is a France-based medical technology company specializing in therapeutic ultrasound solutions for urology. The company operates within the medical devices and healthcare technology industries, with a primary focus on non-invasive and minimally invasive treatments for prostate diseases and urinary stones. EDAP’s core offerings are built around proprietary high-intensity focused ultrasound (HIFU) technology and advanced extracorporeal shock wave lithotripsy systems.

The company’s principal revenue drivers are its prostate cancer treatment platform Focal One®, its robotic HIFU solutions, and its lithotripsy and endourology product lines. EDAP primarily serves hospitals, academic medical centers, and specialty urology clinics, positioning itself as a technology leader in focal therapy for prostate cancer. Founded in 1979, EDAP evolved from a research-driven ultrasound technology company into a publicly listed global medical device manufacturer, with its American Depositary Shares traded on Nasdaq under the ticker EDAP.